Trials
This page lists the trials into DMD and BMD in the UK.
PTC124 in DMD (UK) Phase 2b
| Phase | Drug | Min Age | Max Age | Enrollment | Status |
|---|---|---|---|---|---|
| Phase 2 | PTC-124 | 5 | - | 100 | Recruiting |
Locations: Dubowitz Neuromuscular Centre, Hammersmith Hospital and Institute of Human Genetics, Newcastle upon Tyne
Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy (Exon 51)
| Phase | Drug | Min Age | Max Age | Enrollment | Status |
|---|---|---|---|---|---|
| Phase 1 & 2 | AVI-4658 | 12 | 17 | 9 | Recruiting |
Locations: Dubowitz Neuromuscular Centre, Hammersmith Hospital and Clinical Trails Unit, St Mary's Hospital
Pre-Study Assessment for Systemic Antisense Oligonucleotides in Duchenne Muscular Dystrophy (Exon 51 and 53)
| Phase | Drug | Min Age | Max Age | Enrollment | Status |
|---|---|---|---|---|---|
| Not Applicable | AVI-4658 | 5 | 12 | - | Recruiting |
Locations: Dubowitz Neuromuscular Centre, Hammersmith Hospital and Clinical Trails Unit, St Mary's Hospital

